Stay updated on PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Sign up to get notified when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.

Latest updates to the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page
- Check2 days agoChange DetectedThe page's revision indicator changed from v3.6.4 to v3.6.5, reflecting a background update to the ClinicalTrials.gov interface while the study details remain the same.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision label on the page updated from v3.6.3 to v3.6.4. This reflects a software update to the site rather than a modification to the study information or user-facing content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new published version of the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe study page shows a new revision label (v3.6.2), indicating a recent update to the record that supersedes the previous version (v3.6.0).SummaryDifference0.1%

- Check61 days agoChange DetectedRecruitment status was updated to indicate no participant enrollment; new help and navigation sections were added, and the Intervention/Treatment heading was standardized, with the revision tag updated to v3.6.0.SummaryDifference0.5%

- Check68 days agoChange DetectedRevision version updated from v3.5.4 to v3.5.5, indicating a new page version. This is a metadata update that does not alter visible content or functionality.SummaryDifference0.1%

Stay in the know with updates to PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Enter your email address, and we'll notify you when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.